Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bicycle Therapeutics (BCYC) Restructuring Costs (2024 - 2025)

Bicycle Therapeutics' Restructuring Costs history spans 2 years, with the latest figure at $2.6 million for Q4 2025.

  • For Q4 2025, Restructuring Costs changed 0.0% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $9.6 million, up 5.86%, while the annual FY2025 figure was $9.6 million, 5.86% up from the prior year.
  • Restructuring Costs reached $2.6 million in Q4 2025 per BCYC's latest filing, up from $2.5 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $2.6 million in Q4 2024 to a low of $1.9 million in Q2 2024.